Cancer represents a key challenge in medical science, manifesting as a disease where the immune system fails to recognize and eliminate tumor cells. The phenomenon of immune evasion by cancer cells ...
ImmunityBio, Inc. , a commercial-stage immunotherapy company, today announced updated efficacy and safety results from the ongoing QUILT-106 clinical study (NCT06334991) evaluating an off-the-shelf ...
ImmunityBio, Inc. today announced an update on the status of enrollment in its randomized registrational trial in BCG-naïve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback